MCC and teratoma: The independent tumorigenic pathways for the VP-MCC-like tumor component versus the teratoma component can provide the rationale for the co-presence of VP-MCC-like tumor and teratoma components in this VP-MCC mouse xenograft model, while no mixed VP-MCC and teratoma tumor has been reported in clinical settings.